These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospects for using a blood sample in the diagnosis of heart failure. Struthers AD QJM; 1995 May; 88(5):303-6. PubMed ID: 7796082 [No Abstract] [Full Text] [Related]
3. [Diagnosis of heart failure with the help of natriuretic peptides. Practical tool in primary health care]. Theodorsson E Lakartidningen; 2001 Oct; 98(41):4427. PubMed ID: 11699247 [No Abstract] [Full Text] [Related]
4. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis]. Dahlström U; Alehagen U Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036 [No Abstract] [Full Text] [Related]
6. [Natriuretic cardiac hormones. Clinical use in heart failure]. Nielsen SJ; Gøtze JP; Raymond IE; Grønning BA; Kirk V; Bay-Nielsen M; Hildebrandt PR; Aldershvile J Ugeskr Laeger; 2004 Jan; 166(4):248-53. PubMed ID: 14964102 [No Abstract] [Full Text] [Related]
7. [Natriuretic peptides BNP and NT-pro-BNP--the "new troponins" for estimation of heart failure?]. Pfister R; Erdmann E; Schneider CA Dtsch Med Wochenschr; 2003 May; 128(18):1007-12. PubMed ID: 12721882 [No Abstract] [Full Text] [Related]
8. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure]. Lindstedt G Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037 [No Abstract] [Full Text] [Related]
9. [B-type natriuretic peptide as a predictor of sudden death in chronic heart insufficiency]. Mikkelsen KV; Haghfelt TH Ugeskr Laeger; 2003 Mar; 165(13):1371-2. PubMed ID: 12703288 [No Abstract] [Full Text] [Related]
14. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers for heart failure. Jarolim P Cardiovasc Pathol; 2006; 15(3):144-9. PubMed ID: 16697927 [TBL] [Abstract][Full Text] [Related]
16. Contemporary challenges in translating biomarker evidence into clinical practice. Tang WH J Am Coll Cardiol; 2010 May; 55(19):2077-9. PubMed ID: 20447529 [No Abstract] [Full Text] [Related]
17. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235 [TBL] [Abstract][Full Text] [Related]
18. The role of b-type natriuretic peptide in heart failure management. Newton PJ; Betihavas V; Macdonald P Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695 [TBL] [Abstract][Full Text] [Related]
19. [Measurement of B-type natriuretic peptide in heart failure]. Meland E Tidsskr Nor Laegeforen; 2003 Nov; 123(21):3090. PubMed ID: 14618193 [No Abstract] [Full Text] [Related]
20. B-type natriuretic peptide testing in a nurse-led heart failure clinic. Coady E Nurs Times; 2003 Jul 8-14; 99(27):44-5. PubMed ID: 12882056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]